A Cell Biologist's View on APOL1: What We Know and What We Still Need to Address

被引:0
作者
Hoeffken, Verena [1 ]
Braun, Daniela Anne [1 ]
Pavenstaedt, Hermann [1 ]
Weide, Thomas [1 ]
机构
[1] Univ Hosp Munster, Med Clin D, D-48147 Munster, Germany
关键词
APOL1; Apolipoprotein L1; APOL1-mediated kidney disease; AMKD; renal risk variants; nephrotoxicity; topology; ion pore; ENDOPLASMIC-RETICULUM STRESS; LIPID-BINDING PROTEIN; APOLIPOPROTEIN L1; KIDNEY-DISEASE; RISK VARIANTS; MEMBRANE; GENE; CYTOTOXICITY; EXPRESSION; RESISTANCE;
D O I
10.3390/cells14130960
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
APOL1 is the most recent member of the APOL gene family and is expressed exclusively in humans and a few higher primates. More than twenty years ago, it was discovered that APOL1 protects humans from infections by trypanosome subspecies that cause African sleeping sickness. Interestingly, by a co-evolutionary process between parasite and host, two APOL1 variants emerged, which, in addition to their trypanotoxic effects, are simultaneously associated with a significantly increased risk for various different kidney diseases, which are now summarized as APOL1-mediated kidney diseases (AMKDs). The aim of this review is to highlight and formulate key aspects of APOL1's cell biologic features, including questions and unaddressed aspects. This perspective may contribute to a deeper understanding of APOL1-associated cytotoxicity as well as AMKDs.
引用
收藏
页数:24
相关论文
共 103 条
[1]   The BCL-2 arbiters of apoptosis and their growing role as cancer targets [J].
Adams, Jerry M. ;
Cory, Suzanne .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (01) :27-36
[2]   The critical role of endoplasmic reticulum stress and the stimulator of interferon genes (STING) pathway in kidney fi brosis [J].
Andrade-Silva, Magaiver ;
Dhillon, Poonam ;
Sanchez-Navarro, Andrea ;
Mukhi, Dhanunjay ;
Hu, Hailong ;
Kolligundla, Lakshmi P. ;
Bergeson, Andrea ;
Abedini, Amin ;
Levinsohn, Jonathan ;
Dumoulin, Bernhard ;
Camara, Niels O. S. ;
Miner, Jonathan J. ;
Susztak, Katalin .
KIDNEY INTERNATIONAL, 2025, 107 (02) :302-316
[3]   Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice [J].
Beckerman, Pazit ;
Bi-Karchin, Jing ;
Park, Ae Seo Deok ;
Qiu, Chengxiang ;
Dummer, Patrick D. ;
Soomro, Irfana ;
Boustany-Kari, Carine M. ;
Pullen, Steven S. ;
Miner, Jeffrey H. ;
Hu, Chien-An A. ;
Rohacs, Tibor ;
Inoue, Kazunori ;
Ishibe, Shuta ;
Saleem, Moin A. ;
Palmer, Matthew B. ;
Cuervo, Ana Maria ;
Kopp, Jeffrey B. ;
Susztak, Katalin .
NATURE MEDICINE, 2017, 23 (04) :429-+
[4]   APOL1 variant-expressing endothelial cells exhibit autophagic dysfunction and mitochondrial stress [J].
Blazer, Ashira ;
Qian, Yingzhi ;
Schlegel, Martin Paul ;
Algasas, Huda ;
Buyon, Jill P. ;
Cadwell, Ken ;
Cammer, Michael ;
Heffron, Sean P. ;
Liang, Feng-Xia ;
Mehta-Lee, Shilpi ;
Niewold, Timothy ;
Rasmussen, Sara E. ;
Clancy, Robert M. .
FRONTIERS IN GENETICS, 2022, 13
[5]   Plasma Apolipoprotein L1 Levels Do Not Correlate with CKD [J].
Bruggeman, Leslie A. ;
O'Toole, John F. ;
Ross, Michael D. ;
Madhavan, Sethu M. ;
Smurzynski, Marlene ;
Wu, Kunling ;
Bosch, Ronald J. ;
Gupta, Samir ;
Pollak, Martin R. ;
Sedor, John R. ;
Kalayjian, Robert C. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (03) :634-644
[6]   Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles [J].
Bruno, Jonathan ;
Pozzi, Nicola ;
Oliva, Jonathan ;
Edwards, John C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (44) :18344-18353
[7]   APOL1 promotes endothelial cell activation beyond the glomerulus [J].
Carracedo, Miguel ;
Ericson, Elke ;
Agren, Rasmus ;
Forslow, Anna ;
Madeyski-Bengtson, Katja ;
Svensson, Anna ;
Riddle, Rebecca ;
Christoffersson, Jonas ;
Garibotti, Hernan Gonzalez-King ;
Lazovic, Bojana ;
Hicks, Ryan ;
Buvall, Lisa ;
Fornoni, Alessia ;
Greasley, Peter J. ;
Lal, Mark .
ISCIENCE, 2023, 26 (06)
[8]   Blocking the 5′ splice site of exon 4 by a morpholino oligomer triggers APOL1 protein isoform switch [J].
Cheatham, Amber M. ;
Davis, Shamara E. ;
Khatua, Atanu K. ;
Popik, Waldemar .
SCIENTIFIC REPORTS, 2018, 8
[9]   Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells [J].
Cheng, Dongmei ;
Weckerle, Allison ;
Yu, Yi ;
Ma, Lijun ;
Zhu, Xuewei ;
Murea, Mariana ;
Freedman, Barry I. ;
Parks, John S. ;
Shelness, Gregory S. .
JOURNAL OF LIPID RESEARCH, 2015, 56 (08) :1583-1593
[10]   DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants [J].
Chun, Justin ;
Riella, Cristian, V ;
Chung, Hyunjae ;
Shah, Shrijal S. ;
Wang, Minxian ;
Magraner, Jose M. ;
Ribas, Guilherme T. ;
Ribas, Hennrique T. ;
Zhang, Jia-Yue ;
Alper, Seth L. ;
Friedman, David J. ;
Pollak, Martin R. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (05) :889-907